< BACK

 

Henry Zubaida

 

Henry Zubaida joined Gilde Healthcare in 2018 and is currently an Investment Director. At Gilde he is primarily focusing on investments in medical devices and therapeutics. He has led investments in Arga and ProVerum and serves as a board observer at Volta Medical and Withings. He previously held roles at Biolinq and Accenture. Henry holds a Master’s degree in Bioscience Enterprise from the University of Cambridge.